← brief for 2026-09-24 · Slowing decline

Early adjunctive vasopressin was not associated with a lower 7-day risk of renal replacement therapy in norepinephrine-treated patients with cirrhosis: a target-trial-informed study with external replication

Key takeaways

This study looked at patients with liver disease who were in the ICU. It checked if adding a blood pressure drug early helped protect their kidneys. It found no benefit. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Wei Zhang (Fudan University) · Keyan Miao (Fudan University) · Hui Chen (Fudan University) · Gang Lu (Fudan University) · Ziyang Zhou (Fudan University) · Jianguo Tang (Fudan University)

Source

Article · OpenAlex, CKD works · 2026-09-23
https://doi.org/10.3389/fphar.2026.1941459